SK Biopharmaceuticals. (326030.KQ) Q3 2025 Earnings

Aug 5Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
85
829
1,573
2,318

Details

Expected EPS
397
Actual EPS
384
Surprise EPS
-14
Surprise Percent
-3.43%

Description

⁨SK Biopharmaceuticals.⁩ (⁦326030.KQ⁩) has reported earnings of ⁦384⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts